Acadia (ACAD) Up on FDA Briefing Document for Nuplazid sNDA

Published on 16 Jun 2022 on MSN News

Shares of ACADIA Pharmaceuticals Inc. ACAD gained 15.5% on Wednesday after the FDA issued briefing...

Read the rest of the article

Start tracking your investments with Statfolio

ACADIA Pharmaceuticals Inc (NASDAQ:ACAD), a biopharmaceutical company focused on the development ...

GuruFocus.com via Yahoo Finance 10 Apr 2024

Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) has reported a recent transaction involving its executi...

Investing.com 9 Apr 2024

Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) has reported a recent transaction involving James Kihar...

Investing.com 9 Apr 2024

Stephen Davis, the CEO of ACADIA Pharmaceuticals Inc (NASDAQ:ACAD), has sold 17,714 shares of the...

GuruFocus.com via Yahoo Finance 27 Mar 2024

Monday, Acadia Pharmaceuticals Inc ACAD released top-line results from the Phase 3 ADVANCE-2 tria...

Benzinga 12 Mar 2024

Acadia Pharmaceuticals Inc. ACAD shares lost 15% in the after-market hours on Mar 11, after the c...

Zacks via Yahoo Finance 12 Mar 2024

U.S. stock futures were mixed this morning, with the Nasdaq futures gaining by around 50 points o...

Benzinga 12 Mar 2024

Shares of Acadia Pharmaceuticals Inc. dropped more than 15% in the extended session Monday after ...

Market Watch 11 Mar 2024

Shareholders might have noticed that ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) filed its annual r...

Simply Wall St. via Yahoo Finance 1 Mar 2024

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q4 2023 Earnings Call Transcript February 27, 2024 ACAD...

Insider Monkey via Yahoo Finance 29 Feb 2024